Eric Deutsch, Chairman of Radiation Oncology at Institut Gustave Roussy, shared on LinkedIn:
“ImmunoRad 2026: where radiotherapy meets immunology and innovation.
We are pleased to invite you to the 2026 edition of ImmunoRad, bringing together clinicians, researchers and international experts to explore how radiotherapy is being reshaped by immunology, new technologies and novel therapeutic combinations.
From tumour immunology and radio-immunotherapy to biomarkers, innovative radiation modalities and the next generation of clinical trials, ImmunoRad is designed as a place for scientific exchange, discussion and new collaborations.
If you work in radiation oncology, medical oncology, immunology, translational research, physics, imaging or drug development, join us and be part of the discussion.
Looking forward to seeing many of you at ImmunoRad 2026!”
Other articles about ImmunoRad on OncoDaily.